Marinomed Biotech AG | WebDisclosure

PRESS RELEASE

published on 09/24/2024 at 07:45, 1 year 11 months ago

Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops
Marinomed Biotech AG reports positive clinical results for Carragelose eye drops, improving dry eye symptoms by 54%. The eye drops are well tolerated and hold valid Medical Device Directive certificate

Marinomed Biotech AG Carragelose Clinical Results Dry Eye Eye Drops
BRIEF

published on 09/18/2024 at 17:26, 1 year 11 months ago

Marinomed Biotech AG Announces Capital Increase Excluding Subscription Rights

Investors Capital Increase Marinomed Biotech AG Subscription Rights Issue Price
BRIEF

published on 09/18/2024 at 17:26, 1 year 11 months ago

Marinomed Biotech AG annonce une augmentation de capital hors droits de souscription

Augmentation De Capital Investisseurs Marinomed Biotech AG Droits De Souscription Prix D'émission
PRESS RELEASE

published on 09/18/2024 at 17:21, 1 year 11 months ago

EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Marinomed Biotech AG resolves capital increase by issuing 154,053 bearer shares at EUR 5 per share, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Subscription Rights Bearer Shares EUR 5
BRIEF

published on 09/15/2024 at 17:54, 1 year 11 months ago

Marinomed Biotech AG Sets Price Range for Capital Increases

Capital Increase Restructuring Share Price Investor Negotiations Marinomed Biotech
BRIEF

published on 09/15/2024 at 17:54, 1 year 11 months ago

Marinomed Biotech AG fixe une fourchette de prix pour ses augmentations de capital

Augmentation De Capital Restructuration Cours De L'action Biotechnologie Marinomed Négociations Avec Les Investisseurs
PRESS RELEASE

published on 09/15/2024 at 17:49, 1 year 11 months ago

EQS-Adhoc: Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory subscription rights
Marinomed Biotech AG sets price range for potential 10% capital increase and second capital increase, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Price Range Authorized Capital 2024 Restructuring Proceedings
BRIEF

published on 09/11/2024 at 07:50, 1 year 11 months ago

Marinomed Biotech AG: First Carragelose Products Receive New Medical Device Regulation (MDR) Certification

Regulatory Compliance Medical Devices Carragelose MDR Certification Marinomed
BRIEF

published on 09/11/2024 at 07:50, 1 year 11 months ago

Marinomed Biotech AG : les premiers produits à base de carraghénane reçoivent la nouvelle certification du Règlement sur les dispositifs médicaux (MDR)

Dispositifs Médicaux Conformité Réglementaire Certification MDR Marinomé Carraghénose
PRESS RELEASE

published on 09/11/2024 at 07:45, 1 year 11 months ago

Marinomed Biotech AG: First Carragelose products receive new Medical Device Regulation (MDR) certification
Marinomed Biotech AG's first Carragelose products receive new Medical Device Regulation (MDR) certification, enhancing safety and value for the portfolio

Regulatory Compliance Medical Devices Marinomed Biotech AG MDR Certification Carragelose Products

Published on 09/01/2026 at 13:00, 13 minutes ago

AI/ML Innovations subsidiary NeuralCloud Appoints Former FDA Reviewer Dr. Mehmet Kosoglu as the Head of Regulatory Affairs
Published on 09/01/2026 at 13:00, 13 minutes ago

INEO to Present at Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
Published on 09/01/2026 at 13:00, 13 minutes ago

Pelican AI Corp. Receives Final CSE Approval and Announces Commencement of Trading Under Symbol ''PEL''
Published on 09/01/2026 at 13:00, 13 minutes ago

Prospect Ridge Announces Appointment Of Ellis Martin To Board Of Directors
Published on 09/01/2026 at 12:00, 1 hour 13 minutes ago

NuRAN Wireless Advances Edge AI Infrastructure Strategy for Rural Connectivity Sites in Africa

View all ACCESSWIRE

Published on 09/01/2026 at 13:00, 12 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/01/2026 at 12:51, 21 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 09/01/2026 at 12:48, 24 minutes ago

Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program
Published on 09/01/2026 at 12:45, 27 minutes ago

Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 09/01/2026 at 12:30, 42 minutes ago

InnoHK R&D Centres Establish Base at Science Park to Drive Emerging Industries and Pioneer Future Innovation

View all EQS

Published on 08/31/2026 at 18:00, 19 hours 13 minutes ago

MISE A DISPOSITION RAPPORT FINANCIER ANNUEL 2025/2026
Published on 08/31/2026 at 17:45, 19 hours 28 minutes ago

Disclosure of transactions in own shares from August 24 to August 28, 2026
Published on 08/31/2026 at 17:45, 19 hours 28 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 24 au 28 août 2026
Published on 08/31/2026 at 17:45, 19 hours 28 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 08/31/2026 at 17:45, 19 hours 28 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News